The global Automated Dispensing Machines market was valued at 1236.52 Million USD in 2020 and will grow with a CAGR of 6.02% from 2021 to 2027. During the projected period, rising government activities to support healthcare institutes and pharmacists with

Allscripts' (MDRX) Services Leveraged by Next Level Urgent Care

01:04pm, Tuesday, 23'rd Nov 2021 Zacks Investment Research
Allscripts' (MDRX) Touchworks platform and Microsoft Azure hosting & services will be implemented across all Next Level Urgent Care's sites in Houston.

Here's Why You Should Hold on to Syneos Health (SYNH) for Now

12:52pm, Tuesday, 23'rd Nov 2021 Zacks Investment Research
Investors about optimistic about Syneos Health (SYNH) given its better-than-expected results as well as strong segmental performance during the third quarter.

Omnicell to Present at Upcoming Investor Conferences

09:05pm, Monday, 22'nd Nov 2021 Business Wire
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Omnicell to Present at Upcoming Investor Conferences

3 Reasons Growth Investors Will Love Omnicell (OMCL)

05:45pm, Monday, 22'nd Nov 2021 Zacks Investment Research
Omnicell (OMCL) could produce exceptional returns because of its solid growth attributes.

Here's Why You Should Add Omnicell (OMCL) To Your Portfolio

04:05pm, Monday, 22'nd Nov 2021 Zacks Investment Research
Investors are optimistic about Omnicell (OMCL) owing to its better-than-expected results in the third quarter and robust segmental performance.

Walgreens (WBA) to Offer COVID-19 Vaccine Booster Shots

03:35pm, Monday, 22'nd Nov 2021 Zacks Investment Research
Individuals aged 18 years or older are eligible to avail Pfizer, Moderna or Johnson & Johnson COVID-19 vaccine boosters from Walgreens' (WBA) stores.
Omnicell (OMCL) could produce exceptional returns because of its solid growth attributes.
Investors are optimistic about Omnicell (OMCL) owing to its better-than-expected results in the third quarter and robust segmental performance.

NXGN vs. OMCL: Which Stock Should Value Investors Buy Now?

04:40pm, Thursday, 18'th Nov 2021 Zacks Investment Research
NXGN vs. OMCL: Which Stock Is the Better Value Option?

J.P. Morgan Stick to Their Hold Rating for Omnicell By Investing.com

09:28am, Thursday, 18'th Nov 2021 Investing.com
J.P. Morgan Stick to Their Hold Rating for Omnicell

Invesco Ltd. Has $57.81 Million Stock Holdings in Omnicell, Inc. (NASDAQ:OMCL)

11:22am, Tuesday, 16'th Nov 2021 Dakota Financial News
Invesco Ltd. trimmed its holdings in Omnicell, Inc. (NASDAQ:OMCL) by 8.8% in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 381,685 shares of the companys stock after selling 36,925 shares during the period. Invesco Ltd. owned 0.88% of Omnicell worth $57,806,000 as of its []
Market Snapshot A recently published report by QY Research, titled Global Medication Dispensing and Packaging Systems Market Size, Status and Forecast 2022 gives an overview of the overall Medication Dispensing and Packaging Systems market. This section sheds light on key
Y Intercept Hong Kong Ltd boosted its stake in shares of Omnicell, Inc. (NASDAQ:OMCL) by 27.6% in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 2,286 shares of the companys stock after purchasing an additional 494 shares during the period. Y Intercept Hong Kong Ltds holdings []
Omnicell (OMCL), Fresenius Kabi collaborate to offer safe and efficient dispensing of controlled substances across hospitals and health systems in the United States.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE